TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency. December 19, 2008
TCL Archive Cancer Prevention: HHS Calls for Warning Labels on Cigars, Says Teen Use High March 5, 1999
TCL Archive FDA News: Agency Abandons Plan To Merge Two Offices, Citing Delay Request From Employees’ Union June 19, 1998
